<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02925949</url>
  </required_header>
  <id_info>
    <org_study_id>2R01NR010187-10A1</org_study_id>
    <nct_id>NCT02925949</nct_id>
  </id_info>
  <brief_title>Duo Partnership Adherence Commitment Therapy</brief_title>
  <acronym>DuoPACT</acronym>
  <official_title>A Couples-based Approach to Improving Engagement in HIV Care</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized controlled trial of a new behavioral intervention designed to improve
      engagement in HIV care for same-sex male couples. Investigators will compare the HIV viral
      load outcomes of couples randomized to a couples-based adherence intervention (DuoPACT) or to
      an individual adherence intervention (LifeSteps).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will test the intervention to improve HIV care engagement by enrolling 150
      same-sex male couples and randomizing 75 couples each to one of two conditions: 1) DuoPACT, a
      newly-developed couples intervention; or 2) LifeSteps, a standardized antiretroviral
      adherence intervention for HIV+ individuals. After randomization, intervention sessions will
      be delivered weekly (6 DuoPACT sessions, or 3 Life Steps sessions). All couples will be
      assessed pre/post intervention to evaluate intervention effects via behavioral indicators of
      engagement in HIV care, the couple's relationship dynamics, and the primary outcome of HIV
      viral load.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 14, 2017</start_date>
  <completion_date type="Anticipated">May 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Baseline HIV viral load at 3, 6 and 9 months</measure>
    <time_frame>3, 6 and 9 months</time_frame>
    <description>Follow-up blood draws will be performed on all HIV+ partners at 3, 6, and 9 months post randomization. HIV-1 viral load levels will be measured by the COBAS® AmpliPrep/COBAS® TaqMan® HIV test kit (Roche Molecular Systems, Inc.), which has a threshold for undetectability = &lt; 20 copies/mL.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline behavioral indicators of engagement in HIV care at 3, 6 and 9 months</measure>
    <time_frame>3, 6 and 9 months</time_frame>
    <description>The investigators will use a newly developed 8-point scale called the Behavioral Composite of Engagement in HIV Care, which integrates:
Current/past ART use (participant self-report and verification by HIV medication pill bottles or current pharmacy prescription).
HIV appointment attendance (participant self-report categorized according to current HRSA standards of the minimum annual number and spacing of HIV primary care appointments).
ART adherence (participant self-report and Walsh visual analog scale),
Knowledge of current CD4 cell count (participant self-report).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>HIV/AIDS</condition>
  <arm_group>
    <arm_group_label>DuoPACT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A 6-session HIV medication adherence support program for couples.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LifeSteps</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A 3-session HIV medication adherence support program for individuals.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>DuoPACT</intervention_name>
    <description>6 couple-based intervention sessions are administered weekly by a counselor.</description>
    <arm_group_label>DuoPACT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>LifeSteps</intervention_name>
    <description>3 individual-based intervention sessions are administered weekly by a counselor.</description>
    <arm_group_label>LifeSteps</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. 18+ years old;

          2. Assigned male sex at birth and currently identifies as male;

          3. In a primary romantic relationship with another man for at least 3 months;

          4. At least one partner is HIV+;

          5. English-speaking;

          6. Able to provide informed consent; and

          7. For HIV+ men: Evidence of suboptimal engagement in HIV care.

        Exclusion Criteria:

          1. Must be able to consent to and follow study protocol.

          2. Evidence of severe cognitive impairment or active psychosis.

          3. Plans to relocate from Bay Area in the next 6 months.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mallory O. Johnson, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lara Coffin, MPH</last_name>
    <phone>415-502-5216</phone>
    <email>lara.coffin@ucsf.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Center for AIDS Prevention Studies</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94158</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lara Coffin</last_name>
      <phone>415-502-5216</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 28, 2016</study_first_submitted>
  <study_first_submitted_qc>October 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 6, 2016</study_first_posted>
  <last_update_submitted>February 5, 2018</last_update_submitted>
  <last_update_submitted_qc>February 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Francisco</investigator_affiliation>
    <investigator_full_name>Mallory O. Johnson</investigator_full_name>
    <investigator_title>Co-Director, CAPS</investigator_title>
  </responsible_party>
  <keyword>Treatment</keyword>
  <keyword>Adherence</keyword>
  <keyword>Intervention</keyword>
  <keyword>MSM Couples</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

